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Introduction
Acquired middle ear cholesteatoma remains a
common pathology nowadays. The main treatment is
surgery. Surgeries for cholesteatoma are usually
classified as open or closed procedures. The open
procedure, also known as canal wall-down(CWD)
operation, offers lower rate of cholesteatoma recurrence
but frequently results in postoperative otorrhea, the
latter being mainly due to the absence of the posterior
canal wall and hence exposed mastoid bowl that quite
often catches infection on its surface. The closed
procedure, also called wall-up（CWU）procedure, yields
high rate of "dry ear" but can lead to substantially high
cholesteatoma recurrence rate ［1］ that limits its
employment in patients with constraint health insurance
and, as a consequence, unable to afford second look
operations and in those patients who would, for any
reason, be reluctant to accept a revision operation the
following year after the initial operation.
Posterior canal wall hinders the eradication of choles⁃
teatoma in the middle ear, especially the anterior epitym⁃
panum and posterior tympanum areas, including facial
recess and sinus tympani. This explains the high rate of
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cholesteatoma recurrence in patients subjected to closed
procedure. Removal of the posterior canal wall signifi⁃
cantly reduces the rate of postoperative cholesteatoma re⁃
currence.
The concept of canal wall reconstruction（CWR）
mastoidectomy has been created in an attempt to
combine the advantages of both CWD and CWU
techniques ［2, 3］. The CWR mastoidectomy is a
single-stage technique for cholesteatoma removal and
canal wall reconstruction, and has been used by some
authors in most patients with acquired cholesteatoma,
including children. Herein we present our experiences
in employing this technique.
Material and Method
Between June of 2002 and December of 2005, 38
patients with the diagnosis of cholesteatomatous otitis
media（40 ears）were admitted to the Department of Oto⁃
laryngology, the Second Affiliated Hospital of Sun
Yat-Sen University and were operated on by the author.
Of these patients, 25 were male with an age range be⁃
tween 11 and 60 years（mean = 31.6 years）and 13 were
female patients with an age range between 20 and 65
years（mean = 38.8 years）. CWR mastoidectomy was
performed in 31 ears and CWD mastoidectomy in the re⁃
maining 9 ears, which showed widespread cholesteatoma
involving the posterior canal wall. The posterior canal
wall had to be removed totally in these cases, which
made reconstruction difficult if not impossible. For the
31 CWR operations, concha cartilage was used in 22
cases and cortical mastoid bone was used in the rest 9
for ear canal wall reconstruction. The cortical bone was
the material we used when we first began using the
CWR technique.
The retroauricular approach was used in all cases.
The posterior canal wall skin flap was lifted all the way
down into the tympanum through underneath the tym⁃
panic annula and transected in the middle for visualiza⁃
tion of the tympanic membrane and the retraction pocket
that was usually present in the pars flacida or in the pos⁃
tero-superior portion of the pars tensa. Decorticalization
started either at the antrum if the cholesteatoma extend⁃
ed beyond the antrum or at the lateral wall of the epitym⁃
panum if the cholesteatoma was confined to the epitym⁃
panum. The upper portion of the posterior external ear
canal wall and the lateral wall of the epitympanum were
removed including the so-called“bridge”, an anterolat⁃
eral border of the aditus of the antrum. Cholesteatoma
was removed carefully with special attention paid to the
anterior epitympanum and posterior tympanum includ⁃
ing facial recess and sinus tympani. Following cholestea⁃
toma removal，two grooves were created using 1 mm dia⁃
mond bur, one on the anterior wall of the epitympanum
and another on the facial ridge(Fig.1). Cartilage was har⁃
vested from the concha and cortical bone from behind
the mastoid area. The grafts were shaped to cover the de⁃
fect in the posterior canal wall and put in position with
edges sliding into the two grooves (Fig.2). Fascia tempo⁃
ralis was used to repair the perforation in the eardrum
and PORP or TORP was used to reconstruct the ossicu⁃
lar chain if the stapes was identifiable. In some cases fi⁃
brin glue was used for additional fixation of the canal
wall graft. Ear canal packing was realized with silastic
strips lining the canal wall filled with Merocel soaked
with antibiotic solution. The packing was removed in two
weeks after the operation.
Patients were followed weekly in the first month af⁃
ter the operation with otoscopy and then monthly with
otoendoscopy. They were subjected to audiometry two
months after the operation, documenting the mean
air-bone gap over speech frequencies（500 through
2000 Hz）. Pre- and post-operative hearing results were
compared using the Student's t-test.
Result
Fig 1. Schematic drawing showing structures during a
mastoidectomy, mainly anterior epitympanum(AE) and
tympanic segment of the facial nerve(arrow), exposed after
removal of the upper part of posterior canal wall and lateral
wall of the epitympanum. ME, middle ear cavity; Ma, mastoid
cavity; FR, facial ridge; ICW, inferior canal wall
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The follow up period was 0.5 to 4 years. All but one
patients remained free of the signs of cholesteatoma
recurrence, i.e., presence of retraction pocket and
cholesteatoma matrix. Therefore, the cholesteatoma
recurrence rate was 3.2% (1/31). Cholesteatoma
recurrence was monitored using CT scans whenever
possible. The patient who needed revision surgery at 1.5
year after the initial operation due to recurrence of
cholesteatoma was a smoker. In this case, a retraction
pocket was noticed in the pars flacida area under
otoendoscope that eventually evolved into a
cholesteatoma. The revision surgery revealed an
epithelium pocket filled with cholesteatoma matrix in
the epitympanum. Modified mastoidectomy combined
with meatoplasty was undertaken because the patient
refused considering smoking cessation, which was
considered an important factor for cholesteatoma
recurrence.
For patients subjected to CWR mastoidectomy, pre-
and postoperative mean air-bone gaps were 45 dB and
25 dB respectively（p <0.05）. Using cortical bone or car⁃
tilage for the reconstruction had no impact on pre-/
post-operative air-bone gap change, CT scanning re⁃
sults or otoendoscopic findings.
Discussion
It is not correct, in our opinion, to classify CWR
mastoidectomy as one subtype of closed mastoidectomy.
This is simply because of its significantly lower
cholesteatoma recurrence rate than true closed
procedures with preserved posterior canal walls, despite
the fact that the middle ear and mastoid cavity are
closed at the end of the CWR operation. The 3.2%
recurrence rate in this series is an acceptable outcome
and comparable to Dornhoffer's result ［3］ with CWR
mastoidectomy in 50 ears. The average follow-up in his
study was 7.8 years（6.7-9 years）. with recurrence
occurring in 8 (16%) ears. He considered the results as
an acceptable long-term results.
The case with cholesteatoma recurrence in our study
is a heavy smoker at one pack a day. In such cases,
placement of a tympanic membrane tube after the initial
operation may be helpful in recurrence prevention
because poor Eustachian tube function from tobacco use
may be the cause of recurrence. Dornhoffer reported a
long-term complication rate of 79%（15 of 19） in
smokers in contrast to 16%（5 of 31）in nonsmokers. In
our smoker case, the tube was not placed after the initial
operation because we were not aware of his smoking
history. Due to financial constraints that affects
post-operative follow-up in this patient, a decision was
made not to repeat CWR mastoidectomy with a tympanic
membrane intubation.
Gantz et al. reported a 1.5% cholesteatoma
recurrence rate during a mean postoperative follow up
time of 48 months（range 2-94）in 130 ears（127 adults
and 3 children）receiving CWR tympanomastoidectomy
with mastoid obliteration［2］. The 8 ears with disease
recurrence subsequently received CWD mastoidectomy.
Regarding recurrence of cholesteatoma, Dornhaffer
has pointed out that, although good short-term results
are frequently reported for various techniques of choles⁃
teatoma removal, validation of any approach can only
come with a minimum follow-up of 5 years, preferably
10 years. In the study by Nyrop M, et al［1］, at ten years,
cholesteatoma had recurred in 70% of their patients hav⁃
ing undertaken CWU mastoidectomy, requiring a later
CWD operation. The recurrence rate in a retrospective
study reported by Dornhoffer tripled with longer term fol⁃
low-up, increasing from 5% to 16% . To reduce recur⁃
rence of cholesteatoma, Eustachian tube function should
be carefully monitored and early tympanic membrane
tube placement in patients with poor Eustachian tube
function is warranted. In addition to tobacco use, other
factors can also affect Eustachian tube function. These
Fig 2. Schematic drawing showing the reconstructed
posterior canal wall with the graft (Gr) in place between
the anterior wall of the epitympanum and the facial ridge
(FR). ME, middle ear cavity (be sealed with tympanoplasty
using facia temporalis); Ma, mastoid cavity; ICW, inferior
canal wall.
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factors should be carefully evaluated in all the patients
after mastoidectomy, regardless of the type of the surgi⁃
cal technique used.
The availability of various reconstruction materials
provides the ear surgeon with a variety of options in
CWR mastoidectomy. Although hydroxyapatite cement,
titanium micro-mesh and other artificial materials had
been used with good results［4, 6, 8］，autologous bone and
cartilage grafts seem to be the materials that give the
best results and are, therefore, preferred by ear surgeons
［2, 3, 5, 7, 9］. However, simultaneous reconstruction of the
canal wall, ear drum and ossicular chain can be a
challenge for inexperienced surgeons. .
Conclusion
CWR mastoidectomy can be used in most patients
with acquired cholesteatoma, including children,. This
technique can improve exposure of middle ear
structures, especially the anterior epitympanum, without
creating a mastoid bowl, thus reducing the incidence of
residual and recurrent cholesteatoma and otorrhea.
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